MYD88 and cancer: The activation of the unfolded protein response (UPR) in skeletal muscle during cancer cachexia is facilitated by TLR/MyD88; in turn, the targeted removal of MyD88 reduces the muscle atrophy induced by LLC tumors in mice [127,129].